Systemic Lupus Erythematosus Is Associated With a High Risk of Venous Thromboembolism in Hospitalized Patients Leading to Poor Outcomes and a Higher Cost: Results From Nationwide Inpatient Sample Database 2003-2011.
Shweta KishoreShraddha JatwaniBharat MalhotraSeth T LiretteVarun MittalVikas MajithiaPublished in: ACR open rheumatology (2019)
VTE in hospitalized patients with SLE is associated with significantly higher inpatient mortality, greater disability at discharge, an increased LOS, and higher cost of hospitalization. This cross-sectional study helps with quantifying the risk of VTE in hospitalized patients with SLE and provides information on the immense human and material cost this complication leads to. These data can be very useful in the development and implementation of appropriate prophylactic strategies in the high-risk population with SLE.
Keyphrases
- systemic lupus erythematosus
- venous thromboembolism
- disease activity
- direct oral anticoagulants
- palliative care
- endothelial cells
- mental health
- healthcare
- multiple sclerosis
- primary care
- rheumatoid arthritis
- cardiovascular events
- risk factors
- electronic health record
- emergency department
- acute care
- cross sectional
- adipose tissue
- type diabetes
- induced pluripotent stem cells
- coronary artery disease
- adverse drug
- health information
- glycemic control
- artificial intelligence